Clinigen plans first pharma float in five years
Clinigen, a fast-growing UK company, on Tuesday announced its intention to float on AIM in a deal that will be the first pharmaceuticals IPO in London for five years. It paves the way for the founder and chairman to exit the business.
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article:
- ✔ 4,000 annual insights
- ✔ 700+ notes and long-form analyses
- ✔ 4 capital markets databases
- ✔ Daily newsletters across markets and asset classes
- ✔ 2 weekly podcasts